Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,485 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,566 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06607120 | Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies | unknown | — | 950 | Zhongda HospitalOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT06608043 | Reborn Lifestyle Adjustment Program | unknown | — | 60 | Atlas UniversityOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT06565858 |
| Physical Activity and Sarcoma, Role and Impact on Outcome |
| unknown |
| — |
| 750 |
| European Institute of OncologyOTHER |
| 1 |
| Sep 20, 2024 |
| clinicaltrials |
| NCT03018418 | Proton Therapy in Reducing Toxicity in Anal Cancer | unknown | Phase 2 | 14 | Jordan KharofaOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05625737 | Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma | unknown | Phase 2 | 29 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05793333 | Predictors of Node Positivity in Endometrial Cancer | unknown | — | 200 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06210724 | FIT in Diverticulitis | unknown | — | 275 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06503432 | The Effects of Programmed Death-ligand 1 on Postoperative Pain for Lung Cancer Patients | unknown | — | 100 | Peking University People's HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06586697 | First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy | unknown | Phase 2 | 47 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06587152 | Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical System | unknown | N/A | 60 | Cornerstone RoboticsINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06590194 | PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 96 | Suzhou Puhe Pharmaceutical Technology Co., LTDINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06590844 | "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma | unknown | Phase 4 | 37 | Anhui Provincial HospitalOTHER_GOV | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06590948 | Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS | unknown | — | 50 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06593899 | The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities | unknown | Phase 2 | 51 | Fujian Medical University Union HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06598046 | A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC | unknown | Phase 2 | 48 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06598085 | Clinical Trial Protocol to Evaluate the Efficacy and Safety of Laparoscopic Surgical Systems for Gynaecological Surgery | unknown | N/A | 20 | Cornerstone RoboticsINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05116579 | Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi) | unknown | — | 30 | Sun Yat-sen UniversityOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT05991947 | Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer | unknown | — | 1,100 | Zhejiang Cancer HospitalOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT06585124 | Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas(LA-HLH) | unknown | — | 150 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT05099978 | Asian Multicenter Prospective Study of ctDNA Sequencing(A-TRAIN) | unknown | — | 506 | National Cancer Center, JapanOTHER_GOV | 8 | Sep 4, 2024 | clinicaltrials |
| NCT06481566 | Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial | unknown | N/A | 30 | Chongqing University Cancer HospitalOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT06581107 | Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Lung Cryablation Procedures | unknown | N/A | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 3, 2024 | clinicaltrials |
| NCT06581718 | Eye Gaze Technology for Endoscopic Inspection of the Gastrointestinal Tract | unknown | N/A | 10 | Imperial College LondonOTHER | 1 | Sep 3, 2024 | clinicaltrials |
| NCT03225417 | Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease. | unknown | Phase 1 / Phase 2 | 142 | Fundación Pública Andaluza para la gestión de la Investigación en SevillaOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT06520111 | CRISAL Study:Cancer Risk In Secreting Adrenal Lesions(CRISAL) | unknown | — | 300 | University of Roma La SapienzaOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT06578988 | Use of Artificial Intelligence in the Symptomatic BReAst Clinic SEtting | unknown | — | 25,000 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT03557619 | A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies | unknown | Phase 1 | 12 | AbbVieINDUSTRY | 2 | Aug 29, 2024 | clinicaltrials |
| NCT06577272 | Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients | unknown | — | 6,000 | Tian'an JiangOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT06577311 | Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis) | unknown | Phase 2 | 20 | The Center for Clinical and Cosmetic ResearchOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT06577844 | Evaluation of the Contribution of a DEMaterialized VIdeo-pedagogical SUpport in the Care Pathway of Lung Cancer Surgery Patients(SUVIDEM) | unknown | N/A | 226 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT06578858 | Immunonutrition and Psychosocial Factors in the Recovery of Patients After Gastrectomy: a Multidimensional Analysis | unknown | — | 40 | Universidade Federal de PernambucoOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT00080756 | Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease | unknown | Phase 2 | 11 | City of Hope Medical CenterOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT05272293 | Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML | unknown | Phase 1 / Phase 2 | 15 | Belarusian Research Center for Pediatric Oncology, Hematology and ImmunologyOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT05333302 | Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma | unknown | Phase 1 | 10 | Belarusian Research Center for Pediatric Oncology, Hematology and ImmunologyOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT05334693 | Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML | unknown | Phase 1 / Phase 2 | 15 | Belarusian Research Center for Pediatric Oncology, Hematology and ImmunologyOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT05914662 | Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM(ZBR) | unknown | Phase 2 | 42 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT06468800 | Feasibility and Added Value of the TRACMOTION Device for ESD(TRACMOTION) | unknown | N/A | 20 | Erasmus Medical CenterOTHER | 0 | Aug 28, 2024 | clinicaltrials |
| NCT06564298 | A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver Metastasis | unknown | Phase 2 | 39 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Aug 28, 2024 | clinicaltrials |
| NCT06574763 | Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer | unknown | Phase 2 | 47 | Sun Yat-sen UniversityOTHER | 0 | Aug 28, 2024 | clinicaltrials |
| NCT06575127 | Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study | unknown | Phase 2 | 60 | Al-Azhar UniversityOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT06576180 | Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma | unknown | — | 306 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT04097067 | ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma | unknown | N/A | 83 | University Hospital MuensterOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT04575402 | Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer Patients(DigiPRO) | unknown | — | 40 | Cedars-Sinai Medical CenterOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT05381792 | Serial Gut Microbiome and Bacterial Gene Markers Changes After Endoscopic Resection of Colorectal Advanced Neoplasia(M3-CAN) | unknown | — | 50 | Chinese University of Hong KongOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT05447988 | Motiva Flora Tissue Expander PMCF | unknown | N/A | 136 | Establishment LabsINDUSTRY | 4 | Aug 27, 2024 | clinicaltrials |
| NCT05475184 | A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor | unknown | Phase 2 | 58 | Onconic Therapeutics Inc.INDUSTRY | 1 | Aug 27, 2024 | clinicaltrials |
| NCT05720832 | Feasibility of Technology-Based SSIP in Prostate Cancer Patients | unknown | N/A | 27 | Wings Health AGINDUSTRY | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06347354 | Permanence of Indocyanine Green in Axillary Lymph Nodes 3 Weeks After Subdermal Injection in Patients With Breast Cancer and Metastatic Lymph Nodes(FLUO) | unknown | N/A | 10 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06572410 | Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision | unknown | — | 200 | Elucent MedicalINDUSTRY | 1 | Aug 27, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Sep 23, 2024source: clinicaltrials